Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation) Evaluation of Individual Genetic Susceptibility in Severe Gastro-enteritis Rotavirus: Role of HBGA Polymorphisms & Biotechnology Improvement of RVA Vaccines

NCT02902445 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02902445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02902445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation) Evaluation of Individual Genetic Susceptibility in Severe Gastro-enteritis Rotavirus: Role of HBGA Polymorphisms & Biotechnology Improvement of RVA Vaccines
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
February 28, 2017
Completion date
October 15, 2020
Enrollment
611 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute gastroenteritis, gastroenteritis